|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 2 June 2004
doi: 10.1242/dev.01128
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Neuroanatomy, Interdisciplinary Center of Neuroscience, University of Heidelberg, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
* Author for correspondence (e-mail: horst.simon{at}urz.uni-heidelberg.de)
Accepted 17 February 2004
The neuropathological hallmark of Parkinson’s disease is the loss of dopaminergic neurons in the substantia nigra pars compacta, presumably mediated by apoptosis. The homeobox transcription factors engrailed 1 and engrailed 2 are expressed by this neuronal population from early in development to adulthood. Despite a large mid-hindbrain deletion in double mutants null for both genes, mesencephalic dopaminergic (mDA) neurons are induced, become postmitotic and acquire their neurotransmitter phenotype. However, at birth, no mDA neurons are left. We show that the entire population of these neurons is lost by E14 in the mutant animals, earlier than in any other described genetic model system for Parkinson’s disease. This disappearance is caused by apoptosis revealed by the presence of activated caspase 3 in the dying tyrosine hydroxylase-positive mutant cells. Furthermore, using in vitro cell mixing experiments and RNA interference on primary cell culture of ventral midbrain we were able to show that the demise of mDA neurons in the mutant mice is due to a cell-autonomously requirement of the engrailed genes and not a result of the missing mid-hindbrain tissue. Gene silencing in the postmitotic neurons by RNA interference activates caspase 3 and induces apoptosis in less than 24 hours. This rapid induction of cell death in mDA neurons suggests that the engrailed genes participate directly in the regulation of apoptosis, a proposed mechanism for Parkinson’s disease.
Key words: Transcription factors, Ventral tegmentum, Neurodegenerative disease, Neuronal survival, Neuronal differentiation
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
Related articles in Development:
This article has been cited by other articles:
|
|
 |
|
  Weidong Le, Shen Chen, and J. Jankovic Etiopathogenesis of Parkinson Disease: A New Beginning? Neuroscientist, February 1, 2009; 15(1): 28 - 35. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Sanchez-Pernaute, H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease Brain, August 1, 2008; 131(8): 2127 - 2139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. M. Ferri, W. Lin, Y. E. Mavromatakis, J. C. Wang, H. Sasaki, J. A. Whitsett, and S.-L. Ang Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner Development, August 1, 2007; 134(15): 2761 - 2769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gherbassi, L. Bhatt, S. Thuret, and H. H. Simon Merging Mouse Transcriptome Analyses with Parkinson's Disease Linkage Studies DNA Res, May 23, 2007; (2007) dsm007v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sonnier, G. Le Pen, A. Hartmann, J.-C. Bizot, F. Trovero, M.-O. Krebs, and A. Prochiantz Progressive Loss of Dopaminergic Neurons in the Ventral Midbrain of Adult Mice Heterozygote for Engrailed1 J. Neurosci., January 31, 2007; 27(5): 1063 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sgado, L. Alberi, D. Gherbassi, S. L. Galasso, G. M. J. Ramakers, K. N. Alavian, M. P. Smidt, R. H. Dyck, and H. H. Simon Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice PNAS, October 10, 2006; 103(41): 15242 - 15247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-L. Ang Transcriptional control of midbrain dopaminergic neuron development Development, September 15, 2006; 133(18): 3499 - 3506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Martinat, J.-J. Bacci, T. Leete, J. Kim, W. B. Vanti, A. H. Newman, J. H. Cha, U. Gether, H. Wang, and A. Abeliovich Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype PNAS, February 21, 2006; 103(8): 2874 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Prakash, C. Brodski, T. Naserke, E. Puelles, R. Gogoi, A. Hall, M. Panhuysen, D. Echevarria, L. Sussel, D. M. V. Weisenhorn, et al. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo Development, January 1, 2006; 133(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Miller and H. J. Federoff Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model Systems Neuroscientist, December 1, 2005; 11(6): 539 - 549. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Yan, D. Yang, E. D. Zarnowska, Z. Du, B. Werbel, C. Valliere, R. A. Pearce, J. A. Thomson, and S.-C. Zhang Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells Stem Cells, June 1, 2005; 23(6): 781 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Offner, N. Duval, M. Jamrich, and B. Durand The pro-apoptotic activity of a vertebrate Bar-like homeobox gene plays a key role in patterning the Xenopus neural plate by limiting the number of chordin- and shh-expressing cells Development, April 15, 2005; 132(8): 1807 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Quintanilla, F. J. Munoz, M. J. Metcalfe, M. Hitschfeld, G. Olivares, J. A. Godoy, and N. C. Inestrosa Trolox and 17{beta}-Estradiol Protect against Amyloid {beta}-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway J. Biol. Chem., March 25, 2005; 280(12): 11615 - 11625. [Abstract] [Full Text] [PDF]
|
|
